11C-(R)-rolipram

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name11C-(R)-rolipram
Drug Alias NameCarbon-11-(R)-rolipram(R)-rolipram-[11C]
ClassificationRadiation-emitting products
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsSchizophreniaDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Mental HealthUniversity Of FukuiKyoto University +[5] 
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A